These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Revisiting antiphospholipid antibodies: from targeting phospholipids to phospholipid binding proteins. Bertolaccini ML; Hughes GR; Khamashta MA Clin Lab; 2004; 50(11-12):653-65. PubMed ID: 15575307 [TBL] [Abstract][Full Text] [Related]
3. Association between the prevalence of antibodies to beta(2)-glycoprotein I, prothrombin, protein C, protein S, and annexin V in patients with systemic lupus erythematosus and thrombotic and thrombocytopenic complications. Nojima J; Kuratsune H; Suehisa E; Futsukaichi Y; Yamanishi H; Machii T; Iwatani Y; Kanakura Y Clin Chem; 2001 Jun; 47(6):1008-15. PubMed ID: 11375285 [TBL] [Abstract][Full Text] [Related]
4. Standardization of immunoassays for antiphospholipid antibodies with beta 2GPI and role of other phospholipid cofactors. Amiral J; Larrivaz I; Cluzeau D; Adam M Haemostasis; 1994; 24(3):191-203. PubMed ID: 7527366 [TBL] [Abstract][Full Text] [Related]
5. [Association between anti-phospholipid antibodies and thrombotic complications in systemic lupus erythematosus]. Nojima J Rinsho Byori; 2003 Mar; 51(3):239-47. PubMed ID: 12707997 [TBL] [Abstract][Full Text] [Related]
8. Update on antiphospholipid antibodies. Roubey RA Curr Opin Rheumatol; 2000 Sep; 12(5):374-8. PubMed ID: 10990172 [TBL] [Abstract][Full Text] [Related]
9. Pathogenesis of antiphospholipid antibodies: impairment of fibrinolysis and monocyte activation via the p38 mitogen-activated protein kinase pathway. Yasuda S; Bohgaki M; Atsumi T; Koike T Immunobiology; 2005; 210(10):775-80. PubMed ID: 16325497 [TBL] [Abstract][Full Text] [Related]
10. [New targets of antiphospholipid antibodies]. Arvieux J; Darnige L; Sarrot-Reynauld F Rev Med Interne; 1997; 18(4):292-302. PubMed ID: 9161556 [TBL] [Abstract][Full Text] [Related]
11. [Antiphospholipid-protein antibodies. Effects on the endothelium-platelet interaction]. Forastiero RR; Martinuzzo ME; Carreras LO Sangre (Barc); 1999 Jun; 44(3):223-30. PubMed ID: 10481585 [No Abstract] [Full Text] [Related]
12. Antiphospholipid antibodies from antiphospholipid syndrome patients activate endothelial cells in vitro and in vivo. Pierangeli SS; Colden-Stanfield M; Liu X; Barker JH; Anderson GL; Harris EN Circulation; 1999 Apr; 99(15):1997-2002. PubMed ID: 10209004 [TBL] [Abstract][Full Text] [Related]
13. Probing antiphospholipid-mediated thrombosis: the interplay between anticardiolipin antibodies and endothelial cells. Pierangeli SS; Harris EN Lupus; 2003; 12(7):539-45. PubMed ID: 12892395 [TBL] [Abstract][Full Text] [Related]
14. The role of beta 2-glycoprotein I-dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndrome. Arnout J Verh K Acad Geneeskd Belg; 2000; 62(5):353-72. PubMed ID: 11144685 [TBL] [Abstract][Full Text] [Related]
15. [Antiphospholipid antibodies: clinical significance and biological diagnosis]. Arnoux D; Boutière B; Sanmarco M Ann Biol Clin (Paris); 2000; 58(5):557-74. PubMed ID: 11022099 [TBL] [Abstract][Full Text] [Related]
16. Antiphospholipid-protein antibodies: clinical use of laboratory test results (identification, predictive value, treatment). Triplett DA Haemostasis; 1996 Oct; 26 Suppl 4():358-67. PubMed ID: 8979140 [TBL] [Abstract][Full Text] [Related]
17. New basic aspects of the antiphospholipid syndrome. Hunt JE; Adelstein S; Krilis SA Clin Exp Rheumatol; 1994; 12(6):661-8. PubMed ID: 7895403 [TBL] [Abstract][Full Text] [Related]